articleTop 1% cited
Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
Radiotherapy and Oncology · 1999 · Vol. 52(2) · pp. 137–148
Michele I. Saunders✉(Marie Curie)Stanley Dische(Mount Vernon Hospital)Ann Barrett(Western Infirmary)A Harvey(Medical Research Council)Gareth Griffiths(Medical Research Council)Mahesh Parmar(Medical Research Council)
Lung Cancer Diagnosis and TreatmentLung Cancer Treatments and MutationsHepatocellular Carcinoma Treatment and PrognosisMedicineRelative riskLung cancerRadiation therapyAbsolute risk reductionCancerSubgroup analysisInternal medicineOncologyBasal cell
MeSH terms
AdultAgedCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellFemaleHumansLung NeoplasmsMaleMiddle AgedRadiotherapyRadiotherapy DosageRisk FactorsSurvival RateDisease ProgressionDisease-Free Survival
Citations
482
FWCI
17.45
field-weighted impact
References
30
Percentile
100%
vs. same field & year
Citations per year
Cited by
Improving radiotherapy in cancer treatment: Promises and challenges
Oncotarget · 2017 · 347 citations
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
European Respiratory Journal · 2009 · 908 citations
Guidelines on the radical management of patients with lung cancer
Thorax · 2010 · 535 citations
References
A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer
Radiotherapy and Oncology · 1997 · 472 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.